Literature DB >> 33577621

The PB1 protein of influenza A virus inhibits the innate immune response by targeting MAVS for NBR1-mediated selective autophagic degradation.

Yan Zeng1, Shuai Xu1, Yanli Wei1, Xuegang Zhang1, Qian Wang1, Yane Jia1, Wanbing Wang1, Lu Han1, Zhaoshan Chen1, Zhengxiang Wang1, Bo Zhang2, Hualan Chen2, Cao-Qi Lei3, Qiyun Zhu1.   

Abstract

Influenza A virus (IAV) has evolved various strategies to counteract the innate immune response using different viral proteins. However, the mechanism is not fully elucidated. In this study, we identified the PB1 protein of H7N9 virus as a new negative regulator of virus- or poly(I:C)-stimulated IFN induction and specifically interacted with and destabilized MAVS. A subsequent study revealed that PB1 promoted E3 ligase RNF5 to catalyze K27-linked polyubiquitination of MAVS at Lys362 and Lys461. Moreover, we found that PB1 preferentially associated with a selective autophagic receptor neighbor of BRCA1 (NBR1) that recognizes ubiquitinated MAVS and delivers it to autophagosomes for degradation. The degradation cascade mediated by PB1 facilitates H7N9 virus infection by blocking the RIG-I-MAVS-mediated innate signaling pathway. Taken together, these data uncover a negative regulatory mechanism involving the PB1-RNF5-MAVS-NBR1 axis and provide insights into an evasion strategy employed by influenza virus that involves selective autophagy and innate signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33577621      PMCID: PMC7880438          DOI: 10.1371/journal.ppat.1009300

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  76 in total

1.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Rapid Evolution of H7N9 Highly Pathogenic Viruses that Emerged in China in 2017.

Authors:  Jianzhong Shi; Guohua Deng; Shujie Ma; Xianying Zeng; Xin Yin; Mei Li; Bo Zhang; Pengfei Cui; Yan Chen; Huanliang Yang; Xiaopeng Wan; Liling Liu; Pucheng Chen; Yongping Jiang; Yuntao Guan; Jinxiong Liu; Wenli Gu; Shuyu Han; Yangming Song; Libin Liang; Zhiyuan Qu; Yujie Hou; Xiurong Wang; Hongmei Bao; Guobin Tian; Yanbing Li; Li Jiang; Chengjun Li; Hualan Chen
Journal:  Cell Host Microbe       Date:  2018-09-27       Impact factor: 21.023

3.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.

Authors:  Etienne Meylan; Joseph Curran; Kay Hofmann; Darius Moradpour; Marco Binder; Ralf Bartenschlager; Jürg Tschopp
Journal:  Nature       Date:  2005-09-21       Impact factor: 49.962

4.  Autophagy Promotes Replication of Influenza A Virus In Vitro.

Authors:  Ruifang Wang; Yinxing Zhu; Jiachang Zhao; Chenwei Ren; Peng Li; Huanchun Chen; Meilin Jin; Hongbo Zhou
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

5.  GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.

Authors:  Zihong Chen; Yann Benureau; Rene Rijnbrand; Jianzhong Yi; Ting Wang; Lucile Warter; Robert E Lanford; Steven A Weinman; Stanley M Lemon; Annette Martin; Kui Li
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

6.  Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential.

Authors:  Zsuzsanna T Varga; Alesha Grant; Balaji Manicassamy; Peter Palese
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

7.  Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.

Authors:  Suhong Qian; Wenchun Fan; Tingting Liu; Mengge Wu; Huawei Zhang; Xiaofang Cui; Yun Zhou; Junjie Hu; Shaozhong Wei; Huanchun Chen; Xiangmin Li; Ping Qian
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 8.  Immunomodulatory Nonstructural Proteins of Influenza A Viruses.

Authors:  Carolin Klemm; Yvonne Boergeling; Stephan Ludwig; Christina Ehrhardt
Journal:  Trends Microbiol       Date:  2018-01-17       Impact factor: 17.079

9.  Influenza A Virus PA Antagonizes Interferon-β by Interacting with Interferon Regulatory Factor 3.

Authors:  Chenyang Yi; Zongzheng Zhao; Shengyu Wang; Xin Sun; Dan Zhang; Xiaomei Sun; Anding Zhang; Meilin Jin
Journal:  Front Immunol       Date:  2017-09-11       Impact factor: 7.561

10.  Identification of Amino Acid Residues Responsible for Inhibition of Host Gene Expression by Influenza A H9N2 NS1 Targeting of CPSF30.

Authors:  Laura Rodriguez; Aitor Nogales; Munir Iqbal; Daniel R Perez; Luis Martinez-Sobrido
Journal:  Front Microbiol       Date:  2018-10-24       Impact factor: 5.640

View more
  14 in total

1.  Tembusu Virus Nonstructural Protein 2B Antagonizes Type I Interferon Production by Targeting MAVS for Degradation.

Authors:  Peng Zhou; Yaqian Li; Aixin Liu; Qingxiang Zhang; Wanrong Wu; Hui Jin; Anan Jongkaewwattana; Qigai He; Rui Luo
Journal:  J Virol       Date:  2022-07-11       Impact factor: 6.549

Review 2.  Advances on Innate Immune Evasion by Avian Immunosuppressive Viruses.

Authors:  Hongnuan Wang; Wei Li; Shijun J Zheng
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

3.  Pleiotropic Effects of Influenza H1, H3, and B Baloxavir-Resistant Substitutions on Replication, Sensitivity to Baloxavir, and Interferon Expression.

Authors:  Brady T Hickerson; Simone E Adams; Subrata Barman; Lance Miller; Vladimir Y Lugovtsev; Richard J Webby; William L Ince; Raymond P Donnelly; Natalia A Ilyushina
Journal:  Antimicrob Agents Chemother       Date:  2022-03-09       Impact factor: 5.938

Review 4.  NBR1: The archetypal selective autophagy receptor.

Authors:  Nikoline Lander Rasmussen; Athanasios Kournoutis; Trond Lamark; Terje Johansen
Journal:  J Cell Biol       Date:  2022-10-18       Impact factor: 8.077

Review 5.  Comparing Influenza Virus Biology for Understanding Influenza D Virus.

Authors:  Raegan M Skelton; Victor C Huber
Journal:  Viruses       Date:  2022-05-13       Impact factor: 5.818

Review 6.  Targeting Selective Autophagy as a Therapeutic Strategy for Viral Infectious Diseases.

Authors:  Yishan Liu; Tao Zhou; Jiajia Hu; Shouheng Jin; Jianfeng Wu; Xiangdong Guan; Yaoxing Wu; Jun Cui
Journal:  Front Microbiol       Date:  2022-04-28       Impact factor: 6.064

7.  Temporal transcriptomic changes in long non-coding RNAs and messenger RNAs involved in the host immune and metabolic response during Toxoplasma gondii lytic cycle.

Authors:  Sha-Sha Wang; Chun-Xue Zhou; Hany M Elsheikha; Jun-Jun He; Feng-Cai Zou; Wen-Bin Zheng; Xing-Quan Zhu; Guang-Hui Zhao
Journal:  Parasit Vectors       Date:  2022-01-10       Impact factor: 3.876

Review 8.  The influenza virus RNA polymerase as an innate immune agonist and antagonist.

Authors:  Elizaveta Elshina; Aartjan J W Te Velthuis
Journal:  Cell Mol Life Sci       Date:  2021-10-22       Impact factor: 9.261

9.  MicroRNA-200c-targeted contactin 1 facilitates the replication of influenza A virus by accelerating the degradation of MAVS.

Authors:  Shuai Xu; Lu Han; Yanli Wei; Bo Zhang; Qian Wang; Junwen Liu; Minxuan Liu; Zhaoshan Chen; Zhengxiang Wang; Hualan Chen; Qiyun Zhu
Journal:  PLoS Pathog       Date:  2022-02-16       Impact factor: 6.823

Review 10.  The Multi-Faceted Role of Autophagy During Animal Virus Infection.

Authors:  Hui Jiang; Xianjin Kan; Chan Ding; Yingjie Sun
Journal:  Front Cell Infect Microbiol       Date:  2022-03-25       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.